AlphaStar Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $615K | Buy |
+13,291
| New | +$615K | 0.04% | 207 |
|
2024
Q4 | – | Sell |
-9,379
| Closed | -$485K | – | 229 |
|
2024
Q3 | $485K | Buy |
+9,379
| New | +$485K | 0.04% | 236 |
|
2024
Q1 | – | Sell |
-8,524
| Closed | -$437K | – | 289 |
|
2023
Q4 | $437K | Buy |
+8,524
| New | +$437K | 0.04% | 194 |
|
2023
Q1 | – | Sell |
-6,372
| Closed | -$458K | – | 277 |
|
2022
Q4 | $458K | Sell |
6,372
-277
| -4% | -$19.9K | 0.05% | 215 |
|
2022
Q3 | $473K | Buy |
6,649
+565
| +9% | +$40.2K | 0.05% | 204 |
|
2022
Q2 | $468K | Sell |
6,084
-2,155
| -26% | -$166K | 0.04% | 233 |
|
2022
Q1 | $602K | Buy |
8,239
+1,852
| +29% | +$135K | 0.05% | 228 |
|
2021
Q4 | $415K | Sell |
6,387
-2,509
| -28% | -$163K | 0.03% | 278 |
|
2021
Q3 | $514K | Buy |
+8,896
| New | +$514K | 0.04% | 258 |
|
2020
Q1 | – | Sell |
-10,527
| Closed | -$676K | – | 187 |
|
2019
Q4 | $676K | Buy |
10,527
+1,827
| +21% | +$117K | 0.15% | 107 |
|
2019
Q3 | $441K | Buy |
8,700
+999
| +13% | +$50.6K | 0.11% | 122 |
|
2019
Q2 | $349K | Buy |
+7,701
| New | +$349K | 0.09% | 153 |
|